Introducing a New Paradigm in Neurodegenerative Medicine
Effective treatment of patients with neurodegenerative disorders requires a therapeutic breakthrough. The incidence of neurodegenerative diseases continues to increase as the global population ages and the World Health Organization (WHO) predicts that these diseases will become the second-most prevalent cause of death within the next 20 years.
Bioenergetic Approach
Clene has created new classes of drugs using biologically active nanocrystals to catalyze reactions within the body, enhancing cellular repair and treating neurodegeneration.
CNM-Au8
Clene carefully engineered its lead candidate, CNM-Au8, as a bioenergetic nanocatalyst to enhance critical intracellular bioenergetic reactions necessary for repairing and reversing neuronal damage.